Keith Valentine has bought stock on 4 days since Nov 2016

Keith Valentine is a seasoned executive in the medical device industry with over 30 years of experience, primarily in spine, orthopedics, neurosurgery, and orthobiologics.( He holds a B.B.A. from Western Michigan University (1990)( and began his career at Medtronic Sofamor Danek for eight years, followed by VP of Marketing at ORATEC Interventions (acquired by Smith & Nephew).( Valentine advanced at NuVasive, Inc., serving in senior marketing, development, and operations roles (2001-2007) and as President and COO (2007-2015).( He then became President and CEO of SeaSpine Holdings (2015-2023), leading it until its merger with Orthofix, where he served as President and CEO.(

Currently, Keith Valentine serves as a director on the Board of Directors of Alphatec Holdings, Inc. (NASDAQ: ATEC) since July 2024, after acting as Special Advisor to the Board from October 2023.( He is also CEO of Intrinsic Therapeutics.( Valentine has demonstrated confidence in ATEC through significant open-market purchases, including 135,000 shares on May 7, 8, and 11, 2026, at prices of $7.00–$7.55, increasing his direct holdings to 232,271 shares,( and earlier 39,000 shares on August 2, 2024, at $6.55 average, bringing holdings to 82,140 shares.(

Written by Perplexity from public sources.